Medicare Enrolled
Dr. Carrie Fitzgerald, DO MPH
Urology Physician · Brick, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fitzgerald from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fitzgerald?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fitzgerald
Dr. Carrie Fitzgerald is an urology physician in Brick, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Fitzgerald performed 4,217 Medicare services across 2,349 unique beneficiaries.
Between the years covered by Open Payments, Dr. Fitzgerald received a total of $2,510 from 29 pharmaceutical and/or device companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fitzgerald is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 37% volume in NJ
$2,510 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,217
Medicare services
Top 37% in NJ for urology physician
2,349
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~234 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
715 | $34 | $116 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
682 | $2 | $16 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
363 | $104 | $710 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
295 | $67 | $382 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
288 | $74 | $501 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
233 | $9 | $60 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
186 | $109 | $723 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
165 | $34 | $116 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
165 | $69 | $233 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
131 | $131 | $915 |
| Molecular pathology test interpretation A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report. |
90 | $40 | $102 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
84 | $20 | $128 |
| CMV nucleic acid detection test A laboratory test that uses amplified probe techniques to detect cytomegalovirus (CMV) genetic material in a sample. |
55 | $34 | $116 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
55 | $34 | $116 |
| Herpes simplex virus nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the herpes simplex virus. |
55 | $34 | $116 |
| Herpes virus-6 nucleic acid test A laboratory test that uses amplified probe techniques to detect the genetic material of herpes virus-6. |
55 | $34 | $116 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
55 | $34 | $116 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
55 | $34 | $116 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
55 | $34 | $116 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
55 | $34 | $116 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
52 | $213 | $1,343 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
46 | $9 | $78 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
28 | $67 | $537 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
25 | $50 | $311 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
24 | $490 | $4,154 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
24 | $28 | $369 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
24 | $175 | $1,083 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
24 | $3 | $15 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
23 | $101 | $549 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
22 | $42 | $269 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
18 | $347 | $2,259 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $88 | $616 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
16 | $21 | $191 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
13 | $36 | $204 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $148 | $1,064 |
| Ureteral stent insertion via cystoscopy A tube is placed into the ureter using an endoscope inserted through the bladder. |
11 | $69 | $1,760 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
6.4% medium
93.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,510
Total received (2018-2024)
Avg $359/year across 7 years
Top 46% in NJ for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
85
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,056 (81.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$455 (18.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$570
2023
$644
2022
$588
2021
$185
2020
$27
2019
$100
2018
$396
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Teleflex LLC
$135
PFIZER INC.
$88
Janssen Biotech, Inc.
$62
Myriad Genetic Laboratories, Inc.
$53
Medtronic, Inc.
$50
ABBVIE INC.
$35
Axonics, Inc.
$26
Avation Medical, Inc.
$23
180 Medical, Inc.
$17
Telix Pharmaceuticals
$17
Sumitomo Pharma America, Inc.
$16
Dendreon Pharmaceuticals LLC
$16
COLOPLAST CORP
$16
ABC Home Medical Supply, Inc.
$14
Top 3 companies account for 50.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$490
Astellas Pharma US Inc
$412
Janssen Biotech, Inc.
$178
Teleflex LLC
$159
NeoTract Inc.
$127
Abbott Laboratories
$112
PFIZER INC.
$101
Axonics, Inc.
$100
Boston Scientific Corporation
$95
Coloplast Corp
$88
Myriad Genetic Laboratories, Inc.
$86
Janssen Products, LP
$60
Bayer HealthCare Pharmaceuticals Inc.
$57
DENTSPLY IH AB
$54
Janssen Scientific Affairs, LLC
$53
Sumitomo Pharma America, Inc.
$48
180 Medical, Inc.
$48
Dendreon Pharmaceuticals LLC
$43
ABBVIE INC.
$35
Avation Medical, Inc.
$23
Myovant Sciences Inc.
$17
Accord Healthcare, Inc.
$17
Telix Pharmaceuticals
$17
UroGen Pharma, Inc.
$16
COLOPLAST CORP
$16
Merck Sharp & Dohme LLC
$16
UROVANT SCIENCES INC
$14
ABC Home Medical Supply, Inc.
$14
Progenics Pharmaceuticals, Inc.
$14
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
AMS · Axonics · BOTOX · Bulkamid · CAMCEVI · Coloplast TFL Drive · ERLEADA · Erleada · GEMTESA · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LoFric · Myrbetriq · Nubeqa · ORGOVYX · PERCLOSE PROGLIDE · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · Rezum Generator · SUPERA · SpeediCath · UroLift · UroLift System · Vivally · XTANDI · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
52
Per 100K population
8.0
County median income
$86,411
Nearest hospital
OCEAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fitzgerald is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fitzgerald experienced with infectious disease dna/rna test?
Based on Medicare claims data, Dr. Fitzgerald performed 715 infectious disease dna/rna test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fitzgerald receive payments from pharmaceutical companies?
Yes. Dr. Fitzgerald received a total of $2,510 from 29 companies across 85 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fitzgerald's costs compare to other urology physicians in Brick?
Dr. Fitzgerald's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fitzgerald) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Brick
Browse urology physicians in Brick ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NJ
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NJ
Which NJ urology physicians receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology